You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
There is good news for people in the U.K. who are unsatisfied with the lack of animal insulins. CP Pharmaceuticals of Wrexham, England is now producing beef and pork insulins in cartridges for use with a free pen injection device as well as the normal 10 ml vials.
The following types of animal insulin will now be available in England: Hypurin Porcine Neutral short-acting, Hypurin Porcine Isophane intermediate-acting, and Hypurin Porcine Biphasic - a mixture of 30 percent neutral plus 70 percent isophane.
Available beef insulin include: Hypurin Bovine Neutral short-acting and Hypurin Bovine Isophane intermediate-acting.
Available only in 10 ml vials: Hypurine Bovine PZI long-acting and Hypurine Bovine Lente long-acting.
The free injection device - the Owen Mumford Autopen - is manufactured by Owen Mumford of Woodstock, New York and accepts 1.5 ml cartridges.
Jenny Hirst, chairwoman of the Insulin Dependent Diabetes Trust, was pleased to hear of CP Pharmaceuticals' decision to supply animal insulins. "Thanks to CP, people with diabetes now have an equal choice of insulins, and the market has changed, so that we can feel more secure about our future insulin supplies." To contact CP Pharmaceuticals write: CP Pharmaceuticals Ltd., Ash Road North, Wrexham Industrial Estate, Wrexham, United Kingdom LL139UF or phone: 01-978-666-172
Categories: Animal Insulin, Diabetes, Insulin, Pens
0 comments -
Jul 1, 1997
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.




Email to a Friend
Send a link to this page to your friends and colleagues.